In today’s fast-paced and ever-evolving world, it’s exciting to come across innovative solutions that make our lives easier and improve our health. Kurve Therapeutics is a prime example of this. Kurve was founded by a developer seeking a better solution to his chronic sinusitis. What started as a quest to improve his health has turned into a groundbreaking technology capable of treating complex disorders such as Alzheimer’s, Parkinson’s, and ALS, to name a few. In this interview, we delve deeper into the technology behind Kurve Therapeutics and how it’s turning the tide on cognitive aging.
If you’d like to hear more about how Kurve Therapeutics treats complex Central Nervous System disorders, we invite you to listen to Kurve’s “Reclaim the Brain” podcast. In episode 1, Kurve’s founder and CEO, Marc Giroux, dives into the company’s mission and approach.
Listen now on Spotify:Listen Now
While researching how to treat his chronic sinusitis better, Marc discovered that the traditional way of delivering medicine to the nasal cavity was ineffective. Most people don’t realize that there’s a lot of empty space behind their faces, and spray bottles were not effectively accessing the nasal cavity. Marc’s goal was not only to get medicine all the way through the nasal cavity but also to penetrate the paranasal sinuses — something traditional nasal sprays cannot do.
After researching the science and physics behind fluid dynamics in the nasal cavity, he came up with a solution that reached the roof of the nasal cavity and went all the way back to the ears. The technology was so effective that it opened up opportunities for topical, systemic therapies and central nervous system disorder treatments that can now be accessed through the olfactory region. Kurve Therapeutics is the only company that has proven it can penetrate the brain through the neuronal pathway inside the nasal cavity.
Clinical trials are currently underway in various areas, including PTSD, traumatic brain injury, Parkinson’s, Alzheimer’s, multiple sclerosis, and diabetes, all of which come with cognition issues. The company has a lot of data to support its success, with 18 peer-reviewed studies on nose-to-brain drug delivery. Kurve Therapeutics is outpacing its competition, which is now only focused on systemic treatments. The company’s only main competitors are the infusion companies, who insist that they can treat these disorders chemically and through the circulatory system.
However, infusions are ineffective and only deliver less than one-tenth of 1% of medication to the brain. Infusions are incredibly expensive, costing anywhere from $5,000 to $10,000 a month, and require patients to sit in a chair for up to three hours. Kurve Therapeutics, on the other hand, gets 3,000% more into the brain than infusions and can reduce the dose significantly, making treatments much more effective and cost-efficient.
Kurve’s patented technology has another key feature its competitors do not — dose flexibility. By having control over dose flexibility and delivering higher amounts of medication to the brain than infusions and oral medications, Kurve’s technology has shown the ability to reduce systemic side effects in clinical trials by operating at a lower dose more effectively. In thousands of patients tested, Kurve Therapeutics has had zero brain bleeds, while its competition faces brain bleeds in a significant percentage of its patients.
In short, Kurve Therapeutics is revolutionizing the way we treat complex disorders. The technology Kurve has developed is more effective than traditional treatments, less invasive, and more cost-efficient. By continuously meeting its clinical trial endpoints and significant peer-reviewed studies, Kurve Therapeutics is poised to become a game-changer in the medical world. Kurve’s founder, Marc Giroux, aims to help as many people as possible with his patented technology and sees a bright future for patients suffering from neurodegenerative diseases. Alzheimer’s is just the start for Kurve Therapeutics — as Marc says, “There’s a lot more that we can do in the future,” and we’re excited to see what’s next for Kurve Therapeutics.
Don’t forget to check out Episode 1 of “Reclaim the Brain,” where Marc discusses how Kurve Therapeutics is working to treat complex Central Nervous System disorders. This insightful conversation will give you a better understanding of the company’s innovative approach and how it has the potential to transform lives.Listen Now